Skip to content

Clinical trials

Musculoskeletal Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Country / region: Australia Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20091
20122
20131
20141
20153
20165
20175
20182
20194
20202
20214
20221
20233
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting9
Terminated6
Enrolling by invitation5
Recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie8
BioMarin Pharmaceutical8
QED Therapeutics, a BridgeBio company8
PTC Therapeutics3
Amgen2
Calcilytix Therapeutics, Inc., a BridgeBio company2
Catabasis Pharmaceuticals2
University of Melbourne2
Vertex Pharmaceuticals Incorporated2
Avidity Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases47
Bone Diseases20
Genetic Diseases, Inborn20
Dwarfism15
Osteochondrodysplasias14
Achondroplasia12
Joint Diseases11
Arthritis10
Muscular Diseases10
Mucopolysaccharidosis IV9

Trials

Showing 26 to 47 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.